Our CGx test identifies specific genetic mutations that may increase a patient’s risk of developing or recurring cancer. By analyzing key genes and tumor markers—including BRCA1, BRCA2, ATM, COH1, MLH1, HSH2, MSH6, and PTEN—it provides insights into inherited cancer risks. If a harmful mutation is found in close family members like parents, siblings, or children, their likelihood of developing cancer can be up to eight times higher.

Genetic mutations can contribute to hereditary heart conditions passed down through generations. These inherited disorders include Cardiomyopathy, Arrhythmia, Arteriopathy, and Familial Hypercholesterolemia (FH), each affecting heart function in different ways. Early detection through genetic screening can aid in prevention and management.

The PGX test examines how an individual’s body metabolizes medications, offering insights into drug effectiveness and potential risks. By analyzing genetic variations that influence enzyme activity, this test helps personalize treatments, ensuring safer and more effective drug therapy.

Primary immunodeficiencies are genetic disorders that impair immune system function, making individuals more vulnerable to infections and diseases. These conditions can affect people of any age or gender. Identifying the precise genetic mutation responsible is essential for targeted treatment and management.

This assessment measures cognitive function by comparing brain performance to age-related benchmarks and previous test results. It evaluates the impact of conditions such as dementia, stroke, concussion, and ADHD, helping patients and healthcare providers develop personalized treatment strategies.

Our thyroid disorder test analyzes 112 genes linked to thyroid cancer and conditions like congenital hypothyroidism and thyroid hormone resistance. Each genetic alteration detected in a tumor is evaluated for its relevance to thyroid cancer, including mutations, gene fusions, copy number variations, and gene expression changes, ensuring a precise and informed diagnosis.